SGMT Latest Headlines

SGMT's Exclusive Resmetirom License Signals Bold Step Toward MASH Cirrhosis Therapy

Market Chameleon (Wed, 17-Dec 11:46 AM)

China Accepts Denifanstat New Drug Application for Acne—Key Milestone for Sagimet and Ascletis

Market Chameleon (Wed, 10-Dec 8:18 AM)

Denifanstat Meets All Phase 3 Endpoints in China Acne Trial—Oral FASN Inhibitor Shows Promising Results

Market Chameleon (Fri, 24-Oct 7:34 AM)